Patisiran
Indications
- Stage 1 or stage 2 polyneuropathy in patients with hereditary transthyretin amyloidosis (hATTR) (initiated under specialist supervision)
Safety Information
Side Effects
Common or very common Arthralgia; dyspepsia; dyspnoea; erythema; increased risk of infection; infusion related reaction; muscle spasms; peripheral oedema; vertigo Frequency not known Vitamin A deficie...
Full safety information, contraindications, and dosing available in the MedNext app.
Brand Names
Get the Full Monograph
Complete dosing, interactions, contraindications, side effects, and more for Patisiran.
Download Free — 7-Day TrialNo credit card required
In the MedNext App
- Complete dosing regimens
- Full interaction details & severity
- AI-powered drug search
- All 1 brand names
- Dosing calculators
- CME/CPD tracking
- 40 language support
- Offline access
Source: MedNext Audited Proprietary Dataset
Last reviewed: 2026
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before making clinical decisions. Verify all drug information with current clinical guidelines.
Access all 2866 drugs in the MedNext app
Complete monographs, AI-powered search, interaction checker, dosing calculators, and CME tracking — in 40 languages.
Download MedNext — Free 7-Day Trial